Mawi DNA Technologies (Mawi) has signed a distribution agreement with FUJIFILM Wako Pure Chemical Corporation, to deliver Mawi’s iSWAB bio sampling technologies to Japan.

“The collaboration with FUJIFILM Wako is to provide iSWAB Microbiome-EL sample collection tubes for molecular testing of Covid-19 by PCR and LAMP-based assay and allows us to offer a valuable solution in the Japanese market,” said Atsushi Yanai, Asia Pacific Business Development at Mawi. “Being able to offer the collection without the need for an RNA extraction step complements the WAKO Genomics product range, a valuable solution in the Japanese market and to society.”

FUJIFILM will be an authorized agent and distributor for Mawi products in Japan to detect viruses such as Covid-19

“We are extremely grateful for the opportunity to partner with FUJIFILM, a respected organization with access to key customers in the Japanese market,” added Jerome David, VP of Sales and Marketing at Mawi. “We are confident that this initial partnership around our iSWAB-Microbiome-EL technology for extraction-less detection of SARS-CoV-2 RNA in patient samples will lead to additional opportunities for our entire portfolio of bio sample collection products.”